Gluconorm G
Manufactured by: Lupin Ltd
Contains / Salt: Glimepiride (1 mg) + Metformin (500 mg)
376 people have bought this recently
Gluconorm G
Manufactured by: Lupin Ltd
Contains / Salt: Glimepiride (1 mg) + Metformin (500 mg)
Prescription RequiredSelect the variant of Gluconorm G
15 Tablet in 1 Strip
Add to Cart
Prescription Required
376 people have bought this recently
Membership has been added to your cart.
Gluconorm G Benefits & Uses
Gluconorm G is used to treat the following -
- टाइप 2 मधुमेह
- शुगर Primary (और पढ़ें - शुगर कम करने के घरेलू उपाय)
Gluconorm G Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Log in to view medicine dosage
Ingredients of Gluconorm G
Gluconorm G Side Effects
Based on research, the following side effects have been observed when Gluconorm G is used -
- Anemia Severe
- Hypoglycemia (Low blood sugar level)
- Headache Common
- Nausea or vomiting
- Dizziness Common
- Stomach ache Common
Gluconorm G Related Warnings
Is the use of Gluconorm G safe for pregnant women?
Side effects of Gluconorm G during pregnancy are not known because scientific research on this topic hasn't been done.
UnknownIs the use of Gluconorm G safe during breastfeeding?
Gluconorm G does not show any side effects in breastfeeding women.
SafeWhat is the effect of Gluconorm G on the Kidneys?
Gluconorm G can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
ModerateWhat is the effect of Gluconorm G on the Liver?
Gluconorm G may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
ModerateWhat is the effect of Gluconorm G on the Heart?
Gluconorm G has very mild side effects on the heart.
MildSevere Interaction of Gluconorm G with Other Drugs
Gluconorm G should not be taken with following medicines due to severe side effects it may cause to patients -
Gluconorm G Contraindications
If you are suffering from any of the following diseases, you should not take Gluconorm G unless your doctor advises you to do so -
- Heart Disease
- Kidney Disease
- Liver Disease
- Anemia
Frequently asked Questions about Gluconorm G
Is this Gluconorm G habit forming or addictive?
Gluconorm G is not addictive in nature.
NoIs it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Gluconorm G can make you feel drowsy.
DangerousIs it safe?
Yes, but take Gluconorm G only as per medical advice.
Safe, but take only on Doctor's adviseIs it able to treat mental disorders?
There is no benefit of taking Gluconorm G for mental disorders.
NoGluconorm G Interactions with Food and Alcohol
Interaction between Food and Gluconorm G
Due to the absence of research, it is difficult to say how Gluconorm G and food will interact.
UnknownInteraction between Alcohol and Gluconorm G
Information about the interaction of Gluconorm G and alcohol is not currently available because this topic has not been researched yet.
Unknown
References
- US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
- KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
- April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
- US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
- KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
- April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
